Category News

CHMP Recommends EU Approval of Imfinzi as First Perioperative Immunotherapy for Bladder Cancer

AstraZeneca’s Imfinzi Gains CHMP Backing as First Perioperative Immunotherapy for Muscle-Invasive Bladder Cancer in the EU AstraZeneca has announced a significant regulatory milestone for its cancer immunotherapy, Imfinzi (durvalumab), with the drug receiving a positive recommendation from the Committee for…

Read MoreCHMP Recommends EU Approval of Imfinzi as First Perioperative Immunotherapy for Bladder Cancer

Lupin and SteinCares Announce License and Supply Partnership for Ranibizumab Across Latin America

Lupin and SteinCares Forge Strategic License and Supply Agreement to Commercialize Ranibizumab Biosimilar Across Latin America Global pharmaceutical leader Lupin Limited (Lupin) has officially announced the signing of a significant license and supply agreement with SteinCares, a prominent specialty healthcare…

Read MoreLupin and SteinCares Announce License and Supply Partnership for Ranibizumab Across Latin America

World Health Assembly Extends Global Digital Health Strategy to 2027, Approves 2028–2033 Phase

World Health Assembly Approves Extension of Global Digital Health Strategy to 2027 and Greenlights Next Phase for 2028–2033 In a landmark decision underscoring the accelerating global commitment to digital health, Member States at the Seventy-eighth World Health Assembly (WHA78) have…

Read MoreWorld Health Assembly Extends Global Digital Health Strategy to 2027, Approves 2028–2033 Phase